Lung Cancer Screening in High-risk Black Women

Lung Cancer Clinical Trial

Official title: Evaluating the Feasibility of Lung Cancer Screening in High-risk Black Women

Status Recruiting

Clinical Trial Summary

The goal of this research study is to study U.S. Black women with a history of smoking to examine the feasibility, acceptability, and performance of low-dose computed tomography (LDCT) screening among this population.

The name of the intervention used in this research study is:

Low-dose computed tomography (radiologic scan) chest scan

Clinical Trial Description

The goal of this single-arm pilot research study is to evaluate the feasibility and acceptability of low-dose computed tomography (LDCT) screening for lung cancer among U.S. Black women with a history of smoking.

LDCT screening is currently the only recommended way to screen for lung cancer among high-risk individuals. However, the majority of Black women at high-risk for lunch cancer are currently ineligible for lung cancer screening.

Study procedures include screening for eligibility, completion of questionnaires, and a LDCT screening test.

Participation in this study is expected to last up to 3 months.

It is expected about 900 people will participate in this study. ;

Related Conditions & MeSH terms

• Lung Cancer
• Lung Carcinoma
• Lung Neoplasms

• NCT number: NCT05898594
• Study type: Interventional
• Source: Massachusetts General Hospital
• Contact: Chi Fu Jeffrey Yang, MD
• Phone: 617-724-1681
• Email: cjyang@mgh.harvard.edu
• Status: Recruiting
• Phase: N/A
• Start date: September 6, 2023
• Completion date: June 30, 2028